Boothbay Fund Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Sell |
29,848
-91,425
| -75% | -$3.7M | 0.02% | 473 |
|
|
2025
Q1 | $6.23M | Sell |
121,273
-35,130
| -22% | -$1.8M | 0.16% | 129 |
|
|
2024
Q4 | $8.66M | Sell |
156,403
-119,160
| -43% | -$6.6M | 0.21% | 106 |
|
|
2024
Q3 | $9.06M | Buy |
275,563
+75,469
| +38% | +$2.48M | 0.21% | 90 |
|
|
2024
Q2 | $5.44M | Buy |
200,094
+24,582
| +14% | +$668K | 0.13% | 170 |
|
|
2024
Q1 | $6.38M | Buy |
175,512
+63,740
| +57% | +$2.32M | 0.12% | 132 |
|
|
2023
Q4 | $2.26M | Hold |
111,772
| – | – | 0.06% | 355 |
|
|
2023
Q3 | $1.99M | Buy |
+111,772
| New | +$1.99M | 0.05% | 406 |
|